# Erlotinib alone or with bevacizumab as first-line therapy in patients with advanced non-squamous non-small-cell lung cancer harbouring EGFR mutations (JO25567): an open-label, randomised, multicentre, phase 2 study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/erlotinib-alone-or-with-bevacizumab-as-first-line-therapy-in-patients-with/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Takashi Seto,Terufumi Kato,Makoto Nishio,Kōichi Goto,Shinji Atagi,Yukio Hosomi,Noboru Yamamoto,Noboru Yamamoto,Toyoaki Hida,Makoto Maemondo,Kazuhiko Nakagawa,Seisuke Nagase,Isamu Okamoto,Takeharu Yamanaka,Kosei Tajima,Ryosuke Harada,Masahiro Fukuoka,Nobuyuki Yamamoto,Nobuyuki Yamamoto |
| Citations | 751 |
| DOI | 10.1016/s1470-2045(14)70381-x |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2136601558 |
| PMID | 25175099 |
| Type | article |
| Year | 2014 |

## Paper authors

- [Nobuyuki Yamamoto](https://scholariq.org/researchers/nobuyuki-yamamoto/)
- [Kōichi Goto](https://scholariq.org/researchers/koichi-goto/)

## Paper journal

- [The Lancet Oncology](https://scholariq.org/journals/the-lancet-oncology/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Radiomics and Machine Learning in Medical Imaging](https://scholariq.org/topics/radiomics-and-machine-learning-in-medical-imaging/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.